Evidence map›Paper›PMID 40026944›Full record

ReviewCureus2025

Breaking Barriers in Stroke Therapy: Recent Advances and Ongoing Challenges.

Akkila Goud Bakka, Shweta Shirish Patil, Bhavagna Rachakonda, Abhishek Patil, Jahnavi Bolleddula, Prasanna Sai Kumar Reddy Nandyala, Reva Singamaneni, Nagasaikaran Sade, Prashanth Kumar Patnaik

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akkila Goud BakkaDepartment of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Shweta Shirish PatilDepartment of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Bhavagna RachakondaDepartment of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Abhishek PatilDepartment of Internal Medicine, Shri Bhausaheb Hire Government Medical College, Dhule, IND.
Jahnavi BolleddulaDepartment of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Prasanna Sai Kumar Reddy NandyalaDepartment of Medicine, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Reva SingamaneniDepartment of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Nagasaikaran SadeDepartment of Internal Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.
Prashanth Kumar PatnaikDepartment of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute ischemic stroke remains a significant global health challenge, prompting notable advancements in its management. Diagnostic innovations, including advanced imaging techniques and biomarker discovery, have greatly improved early detection and treatment precision. Mobile stroke units have expedited pre-hospital care, emphasizing the urgency of intervention under the principle "time is brain." These developments underscore the importance of timely and accurate diagnosis in improving outcomes. Therapeutic breakthroughs in thrombolytic therapy and mechanical thrombectomy have transformed acute stroke treatment. Refined thrombolytic protocols, new agents, and extended treatment windows have expanded therapeutic possibilities. Mechanical thrombectomy, bolstered by improved devices and techniques, has achieved higher recanalization rates and broader applicability, solidifying its role in endovascular interventions. Meanwhile, post-stroke care has embraced personalized, multidisciplinary rehabilitation approaches, with telemedicine breaking geographical barriers and enhancing recovery through patient-centered models. Despite these advancements, challenges persist, including disparities in access to advanced care and the underexplored management of minor strokes. Emerging technologies, such as artificial intelligence and machine learning, offer opportunities for better risk prediction and earlier interventions, though their long-term impacts require further study. This review highlights the transformative progress in stroke care while emphasizing the need for continued innovation, research, and equitable access to ensure better outcomes for all patients.

Indexed as

biomarkersischemic strokemechanical thrombectomystroke managementthrombolytic therapy

Identifiers

PMID40026944
PMCPMC11872241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.